Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Eli Lilly Stock Still a Top-Growth Play?

TheMotleyFool

0 0

Is Eli Lilly Stock Still a Top-Growth Play?

Eli Lilly (NYSE: LLY) has been on an epic run of late. Thanks to the excitement over its Alzheimer's disease and weight-loss assets, Lilly's shares have clobbered the broader markets over the past three years. There is a downside associated with Lilly's meteoric rise, however. The company's stock is now trading at over 52 times projected earnings, making it the most expensive big pharma stock right now.